about
Toward a modern synthesis of immunity: Charles A. Janeway Jr. and the immunologist's dirty little secretPathogen recognition and inflammatory signaling in innate immune defensesLipid A modification systems in gram-negative bacteriaCD4(+) T Cell Priming as Biomarker to Study Immune Response to Preventive VaccinesImmune response to vaccine adjuvants during the first year of lifeRadiation as immunomodulator: implications for dendritic cell-based immunotherapyThe Endoplasmic Reticulum Chaperone GRP170: From Immunobiology to Cancer TherapeuticsCellular and molecular mechanisms underlying the strong neonatal IL-12 response of lamb mesenteric lymph node cells to R-848LL37 and cationic peptides enhance TLR3 signaling by viral double-stranded RNAsDNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-AdjuvantExploiting cross-priming to generate protective CD8 T-cell immunity rapidly.Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigenAssociation of interacting genes in the toll-like receptor signaling pathway and the antibody response to pertussis vaccinationThe TLR2 Binding Neisserial Porin PorB Enhances Antigen Presenting Cell Trafficking and Cross-presentation.The Use of Xanthan Gum as Vaccine Adjuvant: An Evaluation of Immunostimulatory Potential in BALB/c Mice and Cytotoxicity In Vitro.Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonistsFunctional comparison of innate immune signaling pathways in primatesDifferential effect of TLR2 and TLR4 on the immune response after immunization with a vaccine against Neisseria meningitidis or Bordetella pertussis.TRIF, and TRIF-interacting TLRs differentially modulate several adenovirus vector-induced immune responses.Toll-like receptor agonists in cancer therapy.Outlining novel cellular adjuvant products for therapeutic vaccines against cancer.Penicillin binding proteins as danger signals: meningococcal penicillin binding protein 2 activates dendritic cells through Toll-like receptor 4.Toll-like receptor agonists: are they good adjuvants?Antigen depot is not required for alum adjuvanticity.A Th1-inducing adenoviral vaccine for boosting adoptively transferred T cells.Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliCTLR8 agonists stimulate newly recruited monocyte-derived cells into potent APCs that enhance HBsAg immunogenicity.Type I Interferons are essential for the efficacy of replicase-based DNA vaccines.The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system.Foxp3+ regulatory T cells impede the priming of protective CD8+ T cells.A neonatal Fc receptor-targeted mucosal vaccine strategy effectively induces HIV-1 antigen-specific immunity to genital infection.Efficient mucosal vaccination mediated by the neonatal Fc receptor.Mechanisms of immunization against cancer using chimeric antigens.Targeting the immunoregulator SRA/CD204 potentiates specific dendritic cell vaccine-induced T-cell response and antitumor immunityAttenuated virulence of a Francisella mutant lacking the lipid A 4'-phosphatase.Gene expression profiles identify both MyD88-independent and MyD88-dependent pathways involved in the maturation of dendritic cells mediated by heparan sulfate: a novel adjuvant.Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1-dependent pathways.Update on toll-like receptor-directed therapies for human diseaseAgonists of Toll-like receptors 3, 4, 7, and 9 are candidates for use as adjuvants in an outer membrane vaccine against Neisseria meningitidis serogroup B.Differential inhibition of human cytomegalovirus (HCMV) by toll-like receptor ligands mediated by interferon-beta in human foreskin fibroblasts and cervical tissue.
P2860
Q24611211-E8954E2A-E7CF-4EF4-B7F5-225E6BF77655Q24643034-E31052A5-9B0F-46F1-B195-39D99DF591FEQ24650951-42B70DC5-2426-40C9-B1DF-E0B3CC626A03Q27014949-E0671681-5AF7-4C17-ABF4-35051BEFE010Q27016633-35BEF923-8C98-468B-A7C4-F01D0048A9A1Q27025756-1831323C-8668-4145-8695-2FB645FE73BFQ27026256-15E94615-80DC-4FC2-9D70-4BA6BD09A2B2Q28475947-6996258A-A3AE-4376-B45F-8EACBFC0EDFEQ28743558-2149566A-6547-46DF-9E96-0D2C71379AB5Q30223578-019108A6-674E-4653-B9BE-3233B7FBAFDAQ30391225-1D093663-DC58-4C8D-B37B-9299BAE58EB1Q33322422-E79D36CA-6D59-4870-A9BA-D5945B04F55CQ33382988-C6DD72D2-0E06-46FC-8977-9281482C074EQ33673210-592A5B1C-325B-456B-98CC-C0FBFC8D1268Q33710401-0A50E78B-BB6B-48A9-B8FE-6181358B37CEQ33721641-4C4030C4-D841-4D6E-81F2-0D6197417951Q33780976-01A80A0D-89C9-45B3-BED2-EBA8DAB91032Q33784386-A8328F81-B51A-4F28-A768-6C3FF92AE193Q33785096-95D77AC8-7827-4F71-ABCB-2161F97389B7Q33918509-D28ED6DB-59C2-4039-9B27-3651FB9F72E2Q33997622-52DA1D02-DB30-4A1D-AD6C-B6416BF95C68Q34064278-80DC4AF9-BDD7-4796-AAD7-7515C3362736Q34067537-B29E6EBA-D219-482D-88BD-5245892DA225Q34235031-D5012BFA-6694-4D75-A57D-44C9652E1791Q34473345-B85C01BF-DFAE-48FE-9A66-E5EDA3676138Q34512085-7D659E94-5A40-4BFA-BFDE-0565560E7163Q34540395-7BAB7A24-B914-46C9-A259-828723F7B647Q34705057-16D8BADC-20EE-4E96-BDFD-5D8FDF99C439Q35018021-9F1778A4-8938-4E2D-A551-EA2D983BFD79Q35175744-4DD8B599-C7D5-4D5E-83AE-8ABF54A322BEQ35274924-09A58911-82D3-4447-84E3-3DAB82C45DFFQ35399345-1C81123F-AB41-4051-800A-0BB4C3CA67FBQ35442846-05293BD0-2818-415D-BEA6-F582BE616E71Q35543558-CDD6C12B-411C-4990-914B-664F53BD142BQ35676813-3FC90BF3-0A41-4EA6-8F8A-5E45361F968CQ35886513-4C336E6C-3075-4F27-86AF-4E513689A987Q36069620-F69A7CEF-8274-491E-A922-72BA6CD0B994Q36171745-7C641505-60F8-48AF-9A13-9C49A9F462DFQ36313996-C9639A7E-32FA-4D62-AFB9-677C21AE63A7Q36419852-9F31FBE7-7876-42DB-BFA0-97D997890A9B
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Triggering TLR signaling in vaccination.
@ast
Triggering TLR signaling in vaccination.
@en
type
label
Triggering TLR signaling in vaccination.
@ast
Triggering TLR signaling in vaccination.
@en
prefLabel
Triggering TLR signaling in vaccination.
@ast
Triggering TLR signaling in vaccination.
@en
P2093
P356
P1433
P1476
Triggering TLR signaling in vaccination.
@en
P2093
Albert C Shaw
David van Duin
Ruslan Medzhitov
P356
10.1016/J.IT.2005.11.005
P577
2005-11-23T00:00:00Z